The relationship between serum tumor-associated trypsin inhibitor levels and clinicopathological parameters in patients with gastric cancer.


BACKGROUND Tumor-associated trypsin inhibitor (TATI) is expressed with trypsinogen in tumors. We studied the clinical-pathologic association and significance of preoperative serum levels of TATI in gastric cancer patients. PATIENTS AND METHODS Pre-treatment serum levels of TATI in patients with gastric cancer and healthy controls were analyzed by a… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.